<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>H&amp;R 1871 Pardner Pump | Rasch Holloway | Activity</title>
	<link>https://pardnerpump.com/members/jetprint73/activity/</link>
	<atom:link href="https://pardnerpump.com/members/jetprint73/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Rasch Holloway.</description>
	<lastBuildDate>Mon, 24 Aug 2026 04:04:16 -0500</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">54d108c13b915923121e5d14337b4747</guid>
				<title>Rasch Holloway posted an update: Multiple Myeloma Settlements: What Plaintiffs Need to Know [&#133;]</title>
				<link>https://pardnerpump.com/activity/p/3856/</link>
				<pubDate>Tue, 18 Aug 2026 18:50:45 -0500</pubDate>

									<content:encoded><![CDATA[<p><strong>Multiple Myeloma Settlements: What Plaintiffs Need to Know</strong> </p>
<p><em>An informative, third‑person guide to the settlement landscape for people detected with multiple myeloma who pursue legal claims.</em> </p>
<p>Intro</p>
<p>Multiple myeloma is a plasma‑cell malignancy that has been connected in clinical literature to a number of occupational and pro&hellip;<span class="activity-read-more" id="activity-read-more-3856"><a href="https://pardnerpump.com/activity/p/3856/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">668748cb84186327a84a670da6794c31</guid>
				<title>Rasch Holloway posted an update: Understanding Multiple Myeloma Lawsuits: Causes, Legal [&#133;]</title>
				<link>https://pardnerpump.com/activity/p/3853/</link>
				<pubDate>Tue, 18 Aug 2026 18:39:06 -0500</pubDate>

									<content:encoded><![CDATA[<p>Understanding Multiple Myeloma Lawsuits: Causes, Legal Grounds, and What Plaintiffs Should Know</p>
<p>Multiple myeloma, a cancer of plasma cells in the bone marrow, provides a substantial health obstacle. While its precise causes aren&#8217;t constantly clear, emerging evidence links particular exposures and medications to an increased threat of&hellip;<span class="activity-read-more" id="activity-read-more-3853"><a href="https://pardnerpump.com/activity/p/3853/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">90d0f4d2b2af4a1c8c7554de57b4660e</guid>
				<title>Rasch Holloway posted an update: Multiple Myeloma Lawsuits: What Patients Need to Know About [&#133;]</title>
				<link>https://pardnerpump.com/activity/p/3851/</link>
				<pubDate>Tue, 18 Aug 2026 18:25:08 -0500</pubDate>

									<content:encoded><![CDATA[<p><strong>Multiple Myeloma Lawsuits: What Patients Need to Know About the Ongoing Litigation</strong> </p>
<p><em>By [Your Name], Health &amp; &amp; Legal Correspondent</em> </p>
<p>Introduction</p>
<p>Multiple myeloma is an incurable cancer of plasma cells that has actually been connected, in several scientific research studies, to long‑term direct exposure to particular chemicals&#8211; most e&hellip;<span class="activity-read-more" id="activity-read-more-3851"><a href="https://pardnerpump.com/activity/p/3851/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">cfa05fcc3be2bc7e92594db277827727</guid>
				<title>Rasch Holloway became a registered member</title>
				<link>https://pardnerpump.com/activity/p/3842/</link>
				<pubDate>Tue, 18 Aug 2026 17:51:23 -0500</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>